A detailed history of Capital Market Strategies LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Capital Market Strategies LLC holds 1,745 shares of ZTS stock, worth $305,043. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,745
Previous 1,745 -0.0%
Holding current value
$305,043
Previous $295,000 2.37%
% of portfolio
0.2%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

SELL
$165.67 - $199.94 $1,159 - $1,399
-7 Reduced 0.4%
1,745 $295,000
Q2 2023

Jul 06, 2023

BUY
$160.94 - $186.23 $281,966 - $326,274
1,752 New
1,752 $301,000
Q4 2022

Jan 17, 2023

SELL
$131.14 - $157.47 $3,934 - $4,724
-30 Reduced 1.68%
1,752 $0
Q3 2022

Oct 14, 2022

SELL
$148.29 - $182.55 $9,342 - $11,500
-63 Reduced 3.41%
1,782 $264,000
Q4 2021

Feb 07, 2022

BUY
$193.69 - $247.03 $357,358 - $455,770
1,845 New
1,845 $450,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Capital Market Strategies LLC Portfolio

Follow Capital Market Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Market Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Market Strategies LLC with notifications on news.